Primary Site >> Liver Cancer

Gene >> CLC

  • 1990
  • 1992
  • 2003
  • 2011
  • 2013
  • 2014
  • 2016
Ref: [Evaluation of plasma tissue plasminogen activator (I-PA) levels in patients with liver diseases].
PMID: 2109806
Ref: Clinical evaluation of tissue plasminogen activator (t-PA) levels in patients with liver diseases.
PMID: 1313384
Ref: Manumycin inhibits cell proliferation and the Ras signal transduction pathway in human hepatocellular carcinoma cells.
PMID: 12736720
Ref: Interferon therapy following treatment of recurrent hepatocellular carcinoma in an 83-year-old man with hepatitis C virus-related liver cirrhosis.
PMID: 26190718
Ref: Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
PMID: 23482775
Ref: Development of global consensus sequence of HCV glycoproteins involved in viral entry.
PMID: 23575038
Ref: Synthesis of new N,N'-bis[1-aryl-3-(piperidine-1-yl)propylidene]hydrazine dihydrochlorides and evaluation of their cytotoxicity against human hepatoma and breast cancer cells.
PMID: 23859151
Ref: [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
PMID: 26956962